Navigation Links
Genomic Health Announces Third Quarter 2008 Financial Results and Business Progress
Date:11/5/2008

study in colon

cancer, with the goal of reporting results in 2009.

Peer-Reviewed Publications and Medical Meeting Presentations

-- Two abstracts were accepted for oral presentation at the San Antonio

Breast Cancer Symposium in December 2008:

-- "Risk of distant recurrence using Oncotype DX in postmenopausal

primary breast cancer patients treated with anastrozole or

tamoxifen: a TransATAC study"

-- "GRB7-dependent pathways are potential therapeutic targets in

triple-negative breast cancer"

-- The American Journal of Surgery published results of a study showing

Oncotype DX changed treatment recommendations in 44 percent of node-

negative, estrogen receptor-positive breast cancer patients.

-- Presented results from two studies supporting the use of Oncotype DX in

assessing HER2 gene expression at the ASCO Breast Cancer Symposium in

September.

-- Independent researchers presented results from a small study of

Japanese women demonstrating that the Oncotype DX Recurrence Score(R)

result may predict response to neoadjuvant endocrine therapy including

tamoxifen and anastrozole at the ASCO Breast Cancer Symposium in

September.

Conference Call Details

To access the live conference call today, November 5, at 4:30 p.m. Eastern Time via phone, please dial (877) 356-8064 from the United States and Canada or (706) 758-4314 internationally. The conference ID is 71000165. Please dial in approximately ten minutes prior to the start of the call. A telephone replay will be available beginning approximately one hour after the call through November 12 and may be accessed by dialing (800) 642-1687 from the United States and Canada or (706) 645-9291 internationally. The replay passcode is 71000165.

To access the live and subsequently archived webcast of the conference call, go to the Invest
'/>"/>

SOURCE Genomic Health, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Transgenomic, Inc. Reports Second Quarter 2007 Results
2. Rosetta Genomics Announces Annual General Meeting of Shareholders to be Held on September 24, 2007
3. GeneNews Chief Scientist Dr. C.C. Liew co-editor of new genomics reference book
4. CODA Genomics Announces Issuance of Optimized Synthetic Gene Production Patent
5. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
6. WallSt.net (www.wallst.net) Announces Upcoming Interview With CEO of DNAPrint Genomics
7. NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma
8. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
9. Rosetta Genomics to Webcast Presentation at Maxim Group Growth Conference
10. BioNanoatrix and Complete Genomics Receive $8.8 Million NIST-ATP Award to Develop Sequencing Platform for $100 Genome
11. BioNanomatrix and Complete Genomics Receive $8.8 Million NIST-ATP Award to Develop Sequencing Platform for $100 Genome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... TORONTO , March 5, 2015 /PRNewswire/ - Aptose Biosciences ... new therapeutics and molecular diagnostics that target the underlying ... Rice , Ph.D., Chairman, President and Chief Executive Officer, ... on Tuesday, March 10 th at 9:30 a.m. ... Niguel, CA. Dr. Rice will provide a ...
(Date:3/5/2015)... DUBLIN , Mar. 05, 2015 Research and ... addition of the "Mature Biotech Outlook 2015: New ... to their offering. All biotech companies ... Celgene (CELG), in past year, have given a positive ... These companies have been able to select therapy/niche indication ...
(Date:3/5/2015)... e2b teknologies , a premier ... Northeast Ohio, today announced a leading independent multi-specialty physician ... upgrade to the latest version of Sage 100 ... of its kind in the region, the organization has ... so efficiency and data accessibility are paramount to their ...
(Date:3/5/2015)... 2015 RMI specializes ... orthopedic conditions such as meniscal tears, ACL injuries, ... joint pain due to degenerative conditions like osteoarthritis. ... surgeries to promote better post-surgical outcomes. , Stemnexa ... pain-free bone marrow harvesting with two complimentary cellular ...
Breaking Biology Technology:Aptose Biosciences to Present at the 27th Annual ROTH Conference 2Aptose Biosciences to Present at the 27th Annual ROTH Conference 3Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success 2Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success 3Physician Group Practice Chooses e2b teknologies to Support Its Upgrade to Sage 100 ERP 2014 2Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas on Friday, March 6th from 5:30 pm to 7:30 pm. 2Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas on Friday, March 6th from 5:30 pm to 7:30 pm. 3Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas on Friday, March 6th from 5:30 pm to 7:30 pm. 4Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas on Friday, March 6th from 5:30 pm to 7:30 pm. 5
... - Presentation to be Webcast -, MONTVALE, N.J., May ... that Noah Berkowitz, M.D., Ph.D. President,and Chief Executive Officer of ... Global Healthcare Conference on Monday, May 19, 2008,at 12:10 p.m. ... May 19-20,2008 at the Le Meridien Beach Plaza Hotel in ...
... EDISON, N.J., May 12 Informed Medical ... forums for the,bio-pharmaceutical industry, today announced the ... In this role, Stoogenke will,develop and implement ... with the objective to maintain and grow ...
... the community and its biotech ... ... ) announced today completion of the final phase of its $1 billion,effort ... ceremony at its Indianapolis operations, Lilly officials, along,with participation by Indianapolis Mayor ...
Cached Biology Technology:Synvista Therapeutics to Present at Acumen BioFin Rodman & Renshaw 5th Annual Global Healthcare Conference 2Synvista Therapeutics to Present at Acumen BioFin Rodman & Renshaw 5th Annual Global Healthcare Conference 3Informed Medical Communications Hires New Vice President of Marketing 2Lilly Completes Final Phase of Its Indianapolis Biotechnology Complex 2Lilly Completes Final Phase of Its Indianapolis Biotechnology Complex 3
(Date:3/2/2015)... , March 2, 2015 Synaptics ... developer of human interface solutions, today announced a ... is designed to enable rapid and secure transactions ... module for gaming is a turnkey solution providing ... ability to quickly integrate fingerprint ID solutions into ...
(Date:3/2/2015)... 2015   Neurotechnology , a provider of high-precision ... SentiGaze Software Development Kit (SDK). The SentiGaze algorithm ... off-the-shelf webcams to track eye movements and generate heatmaps ... Heatmaps can be used for applications such as analysis ... The SDK can also be used to develop interfaces ...
(Date:2/24/2015)... -- This report analyzes the worldwide markets for Iris Biometrics ... the US, Canada , Japan ... , Middle East , and ... provided for the period 2013 through 2020. Also, a seven-year ... analytics are derived from primary and secondary research. Company profiles ...
Breaking Biology News(10 mins):Synaptics Unveils New Fingerprint ID Solution for Gamers 2Synaptics Unveils New Fingerprint ID Solution for Gamers 3Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 2Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 3World Iris Biometrics Industry 2World Iris Biometrics Industry 3World Iris Biometrics Industry 4World Iris Biometrics Industry 5World Iris Biometrics Industry 6World Iris Biometrics Industry 7World Iris Biometrics Industry 8World Iris Biometrics Industry 9World Iris Biometrics Industry 10World Iris Biometrics Industry 11
... University of Malaya (UM) today announced the establishment of ... is the first Centre of its kind in improving ... in terms of their diet and disease, conducting research ... and health, providing assistance for the national cancer registry ...
... most often cultivated in the shade of large trees, can ... those parts of the landscape that are deforested and dominated ... to shop ecologically is that when coffee is grown in ... is negative. This is shown by researchers at the ...
... a kidney transplant could depend on where he or she ... University of Florida shows. The shorter the waiting time ... live. A combination of center-related factors could mean up to ... UF study is the first to analyze overall survival chances ...
Cached Biology News:Queen's University Belfast improves Malaysian public health 2Coffee cultivation good for diversity in agrarian settlements but not in forests 2Shorter wait means longer life for kidney transplant candidates 2Shorter wait means longer life for kidney transplant candidates 3
Quantibody Human Angiogenesis Array 1 (1 slide) Class: Quantitative Antibody Arrays Product Group: Antibody Array...
BD IMagnet 1 each...
Hucal Agx Antigen Expression Service Specificity: Hucal Agx ...
... Casein Kinase 1, active MW: ... 150mM NaCl, 0.02% Brij-35, 1mM dithiothreitiol ... Activity data, refer to the Certificate ... enzyme. Purification: ammonium salt precipitation followed ...
Biology Products: